The first 8 weeks of the Austrian SARS-CoV-2 epidemic

Wien Klin Wochenschr. 2021 Apr;133(7-8):364-376. doi: 10.1007/s00508-020-01804-9. Epub 2021 Feb 1.

Abstract

Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV‑2) reached Austria in February 2020. This study aims to describe the first 8 weeks of the Austrian epidemic and reflect on the potential mental health consequences as known at that time.

Methods: Data on Austrian Coronavirus Disease 19 (COVID-19) epidemiological indicators and number of tests were obtained from official registers. Relative risks (RRs) of infection and death from COVID-19 were calculated for sex and age groups (< 65 years and ≥ 65 years). Public health measures introduced to reduce the spread of COVID-19 were identified via online media research. A rapid review of initial evidence on mental health consequences of the pandemic was performed in PubMed and medRxiv.

Results: By 21 April 2020 the case count in Austria was 14,810 after a peak of new daily infections mid-March. The RR of death for age ≥ 65 years was 80.07 (95% confidence interval, CI 52.64-121.80; p < 0.0001) compared to those aged < 65 years. In men the RR of death was 1.44 (95% CI 1.20-1.73; p < 0.0001) compared to women. Wide-ranging public health measures included avoidance of case importation, limitation of social contacts, hygiene measures, testing, case tracking, and the call for COVID-19-related research. International rates of psychiatric symptoms during the initial lockdowns exceeded typical levels: anxiety (6%-51%), depression (17%-48%) and posttraumatic stress (5%-54%).

Conclusion: Data show great vulnerability of older people also in Austria. Severe mental health impacts can be expected with need for proper assessment of the long-term consequences of this pandemic.

Keywords: Austria; COVID-19; Mental health; Public health measures; Relative risk.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Austria / epidemiology
  • COVID-19*
  • Communicable Disease Control
  • Female
  • Humans
  • Male
  • Pandemics
  • SARS-CoV-2*